Skip links

AI Augments and Human Intelligence: An Evolution

Jump To Section

AI and human intelligence

The business world can’t wait to jump into AI and start leveraging the technology for its many well-hyped benefits. According to the International Monetary Fund, it will change nearly 40% of jobs worldwide, and Statista reports that the market for AI technologies, which was around $200 billion in 2023, is expected to grow beyond $1.8 trillion by 2030. 

In light of this, it’s becoming increasingly critical for businesses to adopt an AI-first strategy — a paradigm shift that goes beyond the mobile-first and cloud-first approaches of the past. However, an AI-first strategy isn’t just about relying solely on AI. It’s about ensuring that human intelligence and artificial intelligence can co-exist to deliver the best products, services, and user experiences. The most effective AI adoption involves applying human critical thinking to AI models, augmenting rather than replacing human capabilities.

While it’s tempting for business leaders to roll up their sleeves and start working with AI, there are some prerequisites needed to ensure the technology is leveraged correctly so organizations can reap greater benefits and enjoy a smoother AI journey. 

At the heart of any AI system, particularly large language models (LLMs), lies data — a business’ most precious asset. This data encompasses information about customers, suppliers, products, purchase orders, sales orders, event logs, audit trails, and even data from IoT devices. Businesses can also leverage non-proprietary data purchased from external vendors to help fuel their AI systems, but that data needs to be vetted to ensure accuracy since it didn’t originate in-house.

To harness the power of data effectively, businesses must establish robust data governance policies, ensuring well-defined data classification and stewardship strategies. Aggregating data across the organization and making it accessible from a single source of truth (SSOT) is equally vital. When AI models are built upon such well-curated data, they can truly augment human intelligence across people, processes, and technology.

Empowering people 

As the primary entities applying human intelligence, people stand to gain the most from AI augmentation. While we’re already witnessing LLMs providing answers to human queries, the near future will likely see AI models evolve to actively ask questions and engage in more proactive interactions.

In the business context, AI systems can significantly enhance employee productivity. Meaningful insights generated by AI will help employees learn faster and make smarter, quicker decisions. By ensuring the co-existence of AI and human intelligence, businesses can empower their employees to focus on more strategic and higher-value tasks. Similarly, end-users and consumers will become smarter and more productive as they increasingly interact with AI systems.

Optimizing processes 

AI’s impact extends to business processes across various functions. As LLMs mature in terms of data volume and quality, businesses can iteratively streamline and optimize their processes, leading to improved productivity. With continuously optimized AI systems in place, process improvements and re-engineering can occur more rapidly and frequently. This creates a scenario where both AI and processes (driven by human intelligence) augment each other, benefiting the business, its employees, and its customers.

For example, AI-powered chatbots are already revolutionizing customer service processes in many companies. By handling routine inquiries and providing instant support, these chatbots free up human agents to focus on more complex and nuanced customer issues, ultimately enhancing the overall customer experience.

Transforming technology 

While advancements in computing power and storage have played a significant role in AI’s evolution, businesses must also consider their existing technology assets, such as software applications, infrastructure, and IoT devices. As AI systems mature, it becomes increasingly important for businesses to continuously evaluate and streamline their tech stacks.

The co-existence and integration of AI systems with the broader enterprise tech stack are crucial for continued success. People who manage and support these technology assets can now rely on insights from AI systems to make informed decisions, rapidly evaluating and optimizing their tech stack. In this way, AI augments human intelligence in technology management.

The rise of AI is not without its challenges and risks. Concerns about job displacement, bias, and privacy must be addressed as businesses navigate this new landscape. However, the potential benefits are immense. By augmenting human intelligence across people, processes, and technology, AI is unlocking new opportunities, driving business value, and enhancing customer experiences.

Experts have even coined the term “hybrid intelligence” to describe the powerful co-existence of human and artificial intelligence. Embracing this evolution and harnessing the power of AI to augment human capabilities will be the key to thriving in digital business. The future belongs to businesses that can successfully navigate this frontier, leveraging AI to empower their people, optimize their processes, and transform their technology.

Picture of Reginald John

Reginald John

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Your Enterprise's Full Potential?

Vikas Krishan

Chief Digital Business Officer and Head of the EMEA region

Vikas (Vik) Krishan serves as the Chief Digital Business Officer and Head of the EMEA region for Altimetrik. He is responsible for leading and growing the company’s presence across new and existing client relationships within the region.

Vik is a seasoned executive and brings over 25 years of global experience in Financial Services, Digital, Management Consulting, Pre- and Post-deal services and large/ strategic transformational programmes, gained in a variety of senior global leadership roles at firms such as Globant, HCL, Wipro, Logica and EDS and started his career within Investment Banking. He has developed significant cross industry experience across a wide variety of verticals, with a particular focus on working with and advising the C-Suite of Financial Institutions, Private Equity firms and FinTech’s on strategy and growth, operational excellence, performance improvement and digital adoption.

He has served as the engagement lead on multiple global transactions to enable the orchestration of business, technology, and operational change to drive growth and client retention.

Vik, who is based in London, serves as a trustee for the Burma Star Memorial Fund, is a keen photographer and an avid sportsman.

Megan Farrell Herrmanns

Chief Digital Officer, US Central

Megan is a senior business executive with a passion for empowering customers to reach their highest potential. She has depth and breadth of experience working across large enterprise and commercial customers, and across technical and industry domains. With a track record of driving measurable results, she develops trusted relationships with client executives to drive organizational growth, unlock business value, and internalize the use of digital business as a differentiator.

At Altimetrik, Megan is responsible for expanding client relationships and developing new business opportunities in the US Central region. Her focus is on digital business and utilizing her experience to create high growth opportunities for clients. Moreover, she leads the company’s efforts in cultivating and enhancing our partnership with Salesforce, strategically positioning our business to capitalize on new business opportunities.

Prior to Altimetrik, Megan spent 10 years leading Customer Success at Salesforce, helping customers maximize the value of their investments across their technology stack. Prior to Salesforce, Megan spent over 15 years with Accenture, leading large transformational projects for enterprise customers.

Megan earned a Bachelor of Science in Mechanical Engineering from Marquette University. Beyond work, Megan enjoys playing sand volleyball, traveling, watching her kids soccer games, and is actively involved in a philanthropy (Advisory Council for Cradles to Crayons).

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes